Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3486506 | The Kaohsiung Journal of Medical Sciences | 2010 | 10 Pages |
Abstract
α-Carboline (pyrido[2,3-b]indole) was selected as the basic scaffold for development of antileukemic agents by structural modification. From the structure-activity study, it was found that sequential introduction of 6-acetyl and 9-substituted benzyl groups onto an α-Carboline scaffold resulted in 6-acetyl-9-(3,5-dimethoxybenzyl)-9H-pyrido[2,3-b]indole and 6-acetyl-9-(3,4,5-trimethoxybenzyl)-9H-pyrido[2,3-b]indole with potent cytotoxicity against the HL-60 cell line. These two compounds will be used as new lead compounds for further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)